Interpace Biosciences offers molecular diagnostic tests, pathology services, and bioinformatics for cancer risk evaluation in the US. The company's portfolio includes PancraGEN, PanDNA, ThyGeNEXT, ThyraMIR, and RespriDx tests. Interpace Biosciences primarily serves healthcare institutions and pharmaceutical/biotech industries.